Loading…

Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line

Summary 1. Erythropoietin (EPO) can reverse radiotherapy‐induced anaemia by stimulating bone marrow cells to produce erythrocytes. However, there are limited studies that address the mechanisms by which EPO exerts its beneficial effects in radiotherapy‐induced anaemia. In the present study, we used...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental pharmacology & physiology 2010-05, Vol.37 (5-6), p.624-629
Main Authors: Liu, Yuan-Yuan, She, Zhen-Jue, Yao, Ming-Hui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493
cites cdi_FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493
container_end_page 629
container_issue 5-6
container_start_page 624
container_title Clinical and experimental pharmacology & physiology
container_volume 37
creator Liu, Yuan-Yuan
She, Zhen-Jue
Yao, Ming-Hui
description Summary 1. Erythropoietin (EPO) can reverse radiotherapy‐induced anaemia by stimulating bone marrow cells to produce erythrocytes. However, there are limited studies that address the mechanisms by which EPO exerts its beneficial effects in radiotherapy‐induced anaemia. In the present study, we used a human bone marrow‐derived EPO‐dependent leukaemia cell line UT‐7/EPO that progressed further in erythroid development to evaluate the anti‐apoptotic effects of EPO on irradiated human erythroid progenitor. 2. The UT‐7/EPO cells exposed to γ‐irradiation were cultured in the presence or absence of EPO at a concentration of 7 U/mL. The cell viability, cell apoptosis and the expression of apoptosis‐related proteins Bcl‐2, Bax and caspase 3 were examined. 3. The results showed that EPO protected the viability of human UT‐7/EPO cells exposed to γ‐irradiation. EPO significantly inhibited γ‐irradiation‐induced apoptosis in human UT‐7/EPO cells: a significant decrease in the percentage of apoptotic cells was observed (62, 69 and 62% at 24, 48 and 72 h, respectively). Furthermore, EPO significantly increased the expression of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and decreased the activation of caspase 3 and formation of the p17 and p12 cleavage in similar conditions. 4. In conclusion, EPO exerts anti‐apoptotic effects on irradiated human UT‐7/EPO cells through upregulation of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and by decreasing the activation of caspase 3. These findings may contribute to our understanding of the beneficial function of EPO in radiotherapy‐induced anaemia.
doi_str_mv 10.1111/j.1440-1681.2010.05370.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733250880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733250880</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493</originalsourceid><addsrcrecordid>eNqNkc-O0zAQhy0EYsvCKyDfOLnrP0nsHDhAKQVptXDowt6siTPZuqRJ1k6gfR4egffgmUi2SyVu-GJr_H0zI_0IoYLPxXgutnORJJyJzIi55GOVp0rz-f4RmZ0-HpMZVzxlwmh-Rp7FuOWcpzxTT8nZ6CgplZqRn8tw6Deh7VqPvW-obza-8H2kv38xHwKUHnrfNsw35eCwpNC1Xd9GH2lxoEMX8Hao7wnaVvStq5mk0JS0RBcQom9uab9BCq7330-Yg9hBRKrGaXQz7KCh12umL_DfVRzWNa19g8_JkwrqiC8e7nNy_X65Xnxgl59WHxdvLplLeMZZmRToKoVFDrnMq0zkYGQhhNZZWYqiKGSCSkvuhASAyokKuAHIDRqdmyRX5-TVsW8X2rsBY293Pk5bQIPtEK1WSqbcGD6S5ki60MYYsLJd8DsIByu4nRKyWzsFYacg7JSQvU_I7kf15cOQodhheRL_RjICr4_AD1_j4b8b28Xy8_QafXb0fexxf_IhfLOZVjq1X69Wdr3iN19uFlf2nfoD7aayhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733250880</pqid></control><display><type>article</type><title>Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>SPORTDiscus with Full Text</source><creator>Liu, Yuan-Yuan ; She, Zhen-Jue ; Yao, Ming-Hui</creator><creatorcontrib>Liu, Yuan-Yuan ; She, Zhen-Jue ; Yao, Ming-Hui</creatorcontrib><description>Summary 1. Erythropoietin (EPO) can reverse radiotherapy‐induced anaemia by stimulating bone marrow cells to produce erythrocytes. However, there are limited studies that address the mechanisms by which EPO exerts its beneficial effects in radiotherapy‐induced anaemia. In the present study, we used a human bone marrow‐derived EPO‐dependent leukaemia cell line UT‐7/EPO that progressed further in erythroid development to evaluate the anti‐apoptotic effects of EPO on irradiated human erythroid progenitor. 2. The UT‐7/EPO cells exposed to γ‐irradiation were cultured in the presence or absence of EPO at a concentration of 7 U/mL. The cell viability, cell apoptosis and the expression of apoptosis‐related proteins Bcl‐2, Bax and caspase 3 were examined. 3. The results showed that EPO protected the viability of human UT‐7/EPO cells exposed to γ‐irradiation. EPO significantly inhibited γ‐irradiation‐induced apoptosis in human UT‐7/EPO cells: a significant decrease in the percentage of apoptotic cells was observed (62, 69 and 62% at 24, 48 and 72 h, respectively). Furthermore, EPO significantly increased the expression of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and decreased the activation of caspase 3 and formation of the p17 and p12 cleavage in similar conditions. 4. In conclusion, EPO exerts anti‐apoptotic effects on irradiated human UT‐7/EPO cells through upregulation of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and by decreasing the activation of caspase 3. These findings may contribute to our understanding of the beneficial function of EPO in radiotherapy‐induced anaemia.</description><identifier>ISSN: 0305-1870</identifier><identifier>EISSN: 1440-1681</identifier><identifier>DOI: 10.1111/j.1440-1681.2010.05370.x</identifier><identifier>PMID: 20132233</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>apoptosis ; Apoptosis - drug effects ; Apoptosis - radiation effects ; Bcl-2 ; Bcl-2/Bax ratio ; Blotting, Western ; caspase 3 ; Caspase 3 - metabolism ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Proliferation - radiation effects ; Cell Survival - drug effects ; Cell Survival - radiation effects ; Dose-Response Relationship, Drug ; Enzyme Activation - drug effects ; erythropoietin ; Erythropoietin - pharmacology ; Gamma Rays - adverse effects ; Humans ; Proto-Oncogene Proteins c-bcl-2 - biosynthesis ; Recombinant Proteins ; Up-Regulation ; UT-7/EPO cell line ; γ-irradiation</subject><ispartof>Clinical and experimental pharmacology &amp; physiology, 2010-05, Vol.37 (5-6), p.624-629</ispartof><rights>2010 The Authors. Journal compilation © 2010 Blackwell Publishing Asia Pty Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493</citedby><cites>FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20132233$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yuan-Yuan</creatorcontrib><creatorcontrib>She, Zhen-Jue</creatorcontrib><creatorcontrib>Yao, Ming-Hui</creatorcontrib><title>Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line</title><title>Clinical and experimental pharmacology &amp; physiology</title><addtitle>Clin Exp Pharmacol Physiol</addtitle><description>Summary 1. Erythropoietin (EPO) can reverse radiotherapy‐induced anaemia by stimulating bone marrow cells to produce erythrocytes. However, there are limited studies that address the mechanisms by which EPO exerts its beneficial effects in radiotherapy‐induced anaemia. In the present study, we used a human bone marrow‐derived EPO‐dependent leukaemia cell line UT‐7/EPO that progressed further in erythroid development to evaluate the anti‐apoptotic effects of EPO on irradiated human erythroid progenitor. 2. The UT‐7/EPO cells exposed to γ‐irradiation were cultured in the presence or absence of EPO at a concentration of 7 U/mL. The cell viability, cell apoptosis and the expression of apoptosis‐related proteins Bcl‐2, Bax and caspase 3 were examined. 3. The results showed that EPO protected the viability of human UT‐7/EPO cells exposed to γ‐irradiation. EPO significantly inhibited γ‐irradiation‐induced apoptosis in human UT‐7/EPO cells: a significant decrease in the percentage of apoptotic cells was observed (62, 69 and 62% at 24, 48 and 72 h, respectively). Furthermore, EPO significantly increased the expression of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and decreased the activation of caspase 3 and formation of the p17 and p12 cleavage in similar conditions. 4. In conclusion, EPO exerts anti‐apoptotic effects on irradiated human UT‐7/EPO cells through upregulation of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and by decreasing the activation of caspase 3. These findings may contribute to our understanding of the beneficial function of EPO in radiotherapy‐induced anaemia.</description><subject>apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - radiation effects</subject><subject>Bcl-2</subject><subject>Bcl-2/Bax ratio</subject><subject>Blotting, Western</subject><subject>caspase 3</subject><subject>Caspase 3 - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Proliferation - radiation effects</subject><subject>Cell Survival - drug effects</subject><subject>Cell Survival - radiation effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Activation - drug effects</subject><subject>erythropoietin</subject><subject>Erythropoietin - pharmacology</subject><subject>Gamma Rays - adverse effects</subject><subject>Humans</subject><subject>Proto-Oncogene Proteins c-bcl-2 - biosynthesis</subject><subject>Recombinant Proteins</subject><subject>Up-Regulation</subject><subject>UT-7/EPO cell line</subject><subject>γ-irradiation</subject><issn>0305-1870</issn><issn>1440-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkc-O0zAQhy0EYsvCKyDfOLnrP0nsHDhAKQVptXDowt6siTPZuqRJ1k6gfR4egffgmUi2SyVu-GJr_H0zI_0IoYLPxXgutnORJJyJzIi55GOVp0rz-f4RmZ0-HpMZVzxlwmh-Rp7FuOWcpzxTT8nZ6CgplZqRn8tw6Deh7VqPvW-obza-8H2kv38xHwKUHnrfNsw35eCwpNC1Xd9GH2lxoEMX8Hao7wnaVvStq5mk0JS0RBcQom9uab9BCq7330-Yg9hBRKrGaXQz7KCh12umL_DfVRzWNa19g8_JkwrqiC8e7nNy_X65Xnxgl59WHxdvLplLeMZZmRToKoVFDrnMq0zkYGQhhNZZWYqiKGSCSkvuhASAyokKuAHIDRqdmyRX5-TVsW8X2rsBY293Pk5bQIPtEK1WSqbcGD6S5ki60MYYsLJd8DsIByu4nRKyWzsFYacg7JSQvU_I7kf15cOQodhheRL_RjICr4_AD1_j4b8b28Xy8_QafXb0fexxf_IhfLOZVjq1X69Wdr3iN19uFlf2nfoD7aayhw</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Liu, Yuan-Yuan</creator><creator>She, Zhen-Jue</creator><creator>Yao, Ming-Hui</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201005</creationdate><title>Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line</title><author>Liu, Yuan-Yuan ; She, Zhen-Jue ; Yao, Ming-Hui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - radiation effects</topic><topic>Bcl-2</topic><topic>Bcl-2/Bax ratio</topic><topic>Blotting, Western</topic><topic>caspase 3</topic><topic>Caspase 3 - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Proliferation - radiation effects</topic><topic>Cell Survival - drug effects</topic><topic>Cell Survival - radiation effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Activation - drug effects</topic><topic>erythropoietin</topic><topic>Erythropoietin - pharmacology</topic><topic>Gamma Rays - adverse effects</topic><topic>Humans</topic><topic>Proto-Oncogene Proteins c-bcl-2 - biosynthesis</topic><topic>Recombinant Proteins</topic><topic>Up-Regulation</topic><topic>UT-7/EPO cell line</topic><topic>γ-irradiation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yuan-Yuan</creatorcontrib><creatorcontrib>She, Zhen-Jue</creatorcontrib><creatorcontrib>Yao, Ming-Hui</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yuan-Yuan</au><au>She, Zhen-Jue</au><au>Yao, Ming-Hui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line</atitle><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle><addtitle>Clin Exp Pharmacol Physiol</addtitle><date>2010-05</date><risdate>2010</risdate><volume>37</volume><issue>5-6</issue><spage>624</spage><epage>629</epage><pages>624-629</pages><issn>0305-1870</issn><eissn>1440-1681</eissn><abstract>Summary 1. Erythropoietin (EPO) can reverse radiotherapy‐induced anaemia by stimulating bone marrow cells to produce erythrocytes. However, there are limited studies that address the mechanisms by which EPO exerts its beneficial effects in radiotherapy‐induced anaemia. In the present study, we used a human bone marrow‐derived EPO‐dependent leukaemia cell line UT‐7/EPO that progressed further in erythroid development to evaluate the anti‐apoptotic effects of EPO on irradiated human erythroid progenitor. 2. The UT‐7/EPO cells exposed to γ‐irradiation were cultured in the presence or absence of EPO at a concentration of 7 U/mL. The cell viability, cell apoptosis and the expression of apoptosis‐related proteins Bcl‐2, Bax and caspase 3 were examined. 3. The results showed that EPO protected the viability of human UT‐7/EPO cells exposed to γ‐irradiation. EPO significantly inhibited γ‐irradiation‐induced apoptosis in human UT‐7/EPO cells: a significant decrease in the percentage of apoptotic cells was observed (62, 69 and 62% at 24, 48 and 72 h, respectively). Furthermore, EPO significantly increased the expression of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and decreased the activation of caspase 3 and formation of the p17 and p12 cleavage in similar conditions. 4. In conclusion, EPO exerts anti‐apoptotic effects on irradiated human UT‐7/EPO cells through upregulation of Bcl‐2 protein and the relative Bcl‐2/Bax ratio, and by decreasing the activation of caspase 3. These findings may contribute to our understanding of the beneficial function of EPO in radiotherapy‐induced anaemia.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20132233</pmid><doi>10.1111/j.1440-1681.2010.05370.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-1870
ispartof Clinical and experimental pharmacology & physiology, 2010-05, Vol.37 (5-6), p.624-629
issn 0305-1870
1440-1681
language eng
recordid cdi_proquest_miscellaneous_733250880
source Wiley-Blackwell Read & Publish Collection; SPORTDiscus with Full Text
subjects apoptosis
Apoptosis - drug effects
Apoptosis - radiation effects
Bcl-2
Bcl-2/Bax ratio
Blotting, Western
caspase 3
Caspase 3 - metabolism
Cell Line, Tumor
Cell Proliferation - drug effects
Cell Proliferation - radiation effects
Cell Survival - drug effects
Cell Survival - radiation effects
Dose-Response Relationship, Drug
Enzyme Activation - drug effects
erythropoietin
Erythropoietin - pharmacology
Gamma Rays - adverse effects
Humans
Proto-Oncogene Proteins c-bcl-2 - biosynthesis
Recombinant Proteins
Up-Regulation
UT-7/EPO cell line
γ-irradiation
title Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T10%3A21%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erythropoietin%20inhibits%20%CE%B3-irradiation-induced%20apoptosis%20by%20upregulation%20of%20Bcl-2%20and%20decreasing%20the%20activation%20of%20caspase%203%20in%20human%20UT-7/erythropoietin%20cell%20line&rft.jtitle=Clinical%20and%20experimental%20pharmacology%20&%20physiology&rft.au=Liu,%20Yuan-Yuan&rft.date=2010-05&rft.volume=37&rft.issue=5-6&rft.spage=624&rft.epage=629&rft.pages=624-629&rft.issn=0305-1870&rft.eissn=1440-1681&rft_id=info:doi/10.1111/j.1440-1681.2010.05370.x&rft_dat=%3Cproquest_cross%3E733250880%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4060-d4becf3eb9a929f619a82b11776dd1bbb24e3720c12aaafc1fa08aa98e8798493%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733250880&rft_id=info:pmid/20132233&rfr_iscdi=true